State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| 1 |
Moderna
MRNA
|
+$2.55B |
| 2 |
Analog Devices
ADI
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$1.18B |
| 4 |
Tesla
TSLA
|
+$1.09B |
| 5 |
Match Group
MTCH
|
+$979M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$1.84B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.43B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$612M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$528M |
| 5 |
Oracle
ORCL
|
+$435M |
Sector Composition
| 1 | Technology | 22.2% |
| 2 | Financials | 14.59% |
| 3 | Healthcare | 13.27% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
iShares Core US REIT ETF
USRT
$3.17B
| $3.09M | ﹤0.01% |
52,700
+10,200
| +24% | +$598K |
|
3327
CollPlant Biotechnologies
CLGN
$34.6M
| $3.08M | ﹤0.01% |
182,266
+5,776
| +3% | +$97.5K |
|
3328
TransAlta
TAC
$3.76B
| $3.06M | ﹤0.01% |
288,893
+769
| +0.3% | +$8.15K |
|
3329
ARS Pharmaceuticals
SPRY
$1.04B
| $3.05M | ﹤0.01% |
305,069
+80,750
| +36% | +$806K |
|
3330
Nathan's Famous
NATH
$437M
| $3.04M | ﹤0.01% |
49,681
-500
| -1% | -$30.6K |
|
3331
Consumer Discretionary Select Sector SPDR Fund
XLY
$24B
| $3.03M | ﹤0.01% |
16,903
+2,396
| +17% | +$430K |
|
|
HARP
3332
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $3.03M | ﹤0.01% |
38,372
-94,465
| -71% | -$7.46M |
|
3333
Black Diamond Therapeutics
BDTX
$192M
| $3.01M | ﹤0.01% |
355,703
+21,352
| +6% | +$181K |
|
3334
Intercorp Financial Services
IFS
$4.65B
| $3M | ﹤0.01% |
134,117
-5,529
| -4% | -$123K |
|
|
MILE
3335
DELISTED
Metromile, Inc. Common Stock
MILE
| $2.99M | ﹤0.01% |
843,033
+77,167
| +10% | +$274K |
|
3336
Duolingo
DUOL
$14.2B
| $2.98M | ﹤0.01% |
+17,900
| New | +$2.98M |
|
3337
Advent Technologies
ADN
$8.22M
| $2.97M | ﹤0.01% |
11,394
+1,542
| +16% | +$402K |
|
|
PZN
3338
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $2.97M | ﹤0.01% |
302,138
+5,699
| +2% | +$56.1K |
|
3339
Sight Sciences
SGHT
$179M
| $2.95M | ﹤0.01% |
+130,084
| New | +$2.95M |
|
3340
Day One Biopharmaceuticals
DAWN
$744M
| $2.94M | ﹤0.01% |
+124,032
| New | +$2.94M |
|
|
ADAP
3341
Adaptimmune Therapeutics
ADAP
$13.4M
| $2.94M | ﹤0.01% |
567,209
+307,627
| +119% | +$1.6M |
|
3342
GeneDx Holdings
WGS
$3.62B
| $2.94M | ﹤0.01% |
+11,742
| New | +$2.94M |
|
|
SOLY
3343
DELISTED
Soliton, Inc.
SOLY
| $2.93M | ﹤0.01% |
143,844
+17,804
| +14% | +$363K |
|
3344
Ericsson
ERIC
$26.8B
| $2.92M | ﹤0.01% |
261,980
-130,271
| -33% | -$1.45M |
|
|
NBEV
3345
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $2.92M | ﹤0.01% |
2,097,325
+128,411
| +7% | +$178K |
|
3346
KALA BIO
KALA
$107M
| $2.91M | ﹤0.01% |
22,256
+5,794
| +35% | +$758K |
|
|
AFIB
3347
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $2.9M | ﹤0.01% |
328,256
+109,588
| +50% | +$969K |
|
|
DESP
3348
DELISTED
Despegar.com
DESP
| $2.89M | ﹤0.01% |
240,061
+290
| +0.1% | +$3.49K |
|
3349
89bio
ETNB
$1.26B
| $2.89M | ﹤0.01% |
147,403
-925
| -0.6% | -$18.1K |
|
3350
Viemed Healthcare
VMD
$256M
| $2.88M | ﹤0.01% |
518,686
+1,851
| +0.4% | +$10.3K |
|